Hello jcurve
Report from 2017 page 13 indicates the following; I assume the Patent is still current?
https://botanixpharma.com/wp-content/uploads/2020/06/170322-BOT-Initiation-Report.pdf
The patent for Permetrex is held by Dr Eugene Cooper, who in turn has granted BOT a license for exclusive worldwide use of the drug delivery technology when used with any drug active purposed for the topical treatment of any skin disease. It is the responsibility of Dr Cooper to enforce and defend his intellectual property rights with respect to Permetrex. Any failure to do so, on Dr Cooper’s behalf, may present a significant risk to BOT and its wider portfolio of pipeline products.
BOT - Anything but charting, page-1402
-
- There are more pages in this discussion • 8,664 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.050(14.3%) |
Mkt cap ! $724.0M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 40.0¢ | 35.5¢ | $6.075M | 15.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 287187 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 1920397 | 33 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |